Table 1.

A summary of case reports of MOG-IgG-associated disorders after COVID-19 vaccination.

References	Age	Sex	Vaccine	Interval between vaccination and onset	Symptoms	MRI findings	CSF cell count (/μl)	CSF Protein (mg/dl)	OCBs	Treatment	Outcome
Mumoli et al. (19)	43	Male	ChAdOx1 nCOV-19	7 days after first dose	Bilateral lower limbs weakness urinary retention	Multiple brain white matter lesion and LETM	43	40.6	(+)	IVMP	Mostly recovered
Dams et al. (20)	59	Male	ChAdOx1 nCOV-19	14 days after first dose	paresthesia, gait disturbance, urinary and rectal dysfunction	LETM	110	n.d.	(–)	IVMP and PLEX	Partially recovered
Our case	68	Female	mRNA-1273	14 days after second dose	Paresthesia on her right V2 and V3 area	Cerebellar peduncle lesion	0	32	(+)	IVMP	Partially recovered

MOGAD, MOG antibody associated disorders; CSF, cerebrospinal fluid; OCB, oligoclonal band; LETM, longitudinally extensive transverse myelitis; n.d., not described; IVMP, intravenous methylprednisolone; PLEX, plasma exchange.